COVID-19 rapid guideline: delivery of systemic anticancer treatments

    Ano de publicação: 2020

    The purpose of this guideline is to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandemic.